1. Endometrial stem cell transplantation in MPTP‐ exposed primates: an alternative cell source for treatment of Parkinson's disease. Issue 1 (6th October 2014) Authors: Wolff, Erin F.; Mutlu, Levent; Massasa, Efi E.; Elsworth, John D.; Eugene Redmond, D.; Taylor, Hugh S. Journal: Journal of cellular and molecular medicine Issue: Volume 19:Issue 1(2015) Page Start: 249 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. EP007/#994 Bay 1895344, a novel ATR inhibitor, demonstrates in vivo activity against ATRX altered uterine leiomyosarcoma. (4th December 2022) Authors: Harold, Justin; Manavella, Diego; Bellone, Stefania; Siegel, Eric; Hartwich, Tobias; Zammataro, Luca; Mutlu, Levent; Altwerger, Gary; Menderes, Gulden; Ratner, Elena; Huang, Gloria; Clark, Mitchell; Andikyan, Vaagn; Azodi, Masoud; Schwartz, Peter; Alexandrov, Ludmil; Santin, Alessandro Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 3 Page Start: A51 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. EP015/#546 In vitro and in vivo efficacy of trastuzumab deruxtecan (T-DXd) in epithelial ovarian cancer with HER2/NEU overexpression. (4th December 2022) Authors: Mutlu, Levent; Manavella, Diego; Bellone, Stefania; Santin, Alessandro Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 3 Page Start: A54 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Identification of Putative Fallopian Tube Stem Cells. (December 2014) Authors: Snegovskikh, Victoria; Mutlu, Levent; Massasa, Effi; Taylor, Hugh S. Journal: Reproductive sciences Issue: Volume 21:Number 12(2014:Dec.) Page Start: 1460 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Immune checkpoint inhibitors for recurrent endometrial cancer. Issue 3 (4th March 2022) Authors: Mutlu, Levent; Harold, Justin; Tymon-Rosario, Joan; Santin, Alessandro D. Journal: Expert review of anticancer therapy Issue: Volume 22:Issue 3(2022) Page Start: 249 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Pembrolizumab with chemotherapy, with or without bevacizumab for persistent, recurrent, or metastatic cervical cancer. (4th March 2023) Authors: McNamara, Blair; Chang, Yifan; Mutlu, Levent; Harold, Justin; Santin, Alessandro D Journal: Expert opinion on biological therapy Issue: Volume 23:Number 3(2023) Page Start: 227 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Risk‐stratifying clinicopathologic criteria for ovarian preservation in premenopausal women with early stage low‐risk endometrial cancer. Issue 3 (26th June 2020) Authors: Khadraoui, Wafa; Tierney, Christina; Chung, Sophie; Mutlu, Levent; Lu, Lingeng; Azodi, Masoud; Ratner, Elena; Menderes, Gulden Journal: International journal of gynaecology and obstetrics Issue: Volume 150:Issue 3(2020) Page Start: 385 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Targeted treatment options for the management of metastatic/persistent and recurrent cervical cancer. Issue 6 (3rd June 2022) Authors: Mutlu, Levent; Tymon-Rosario, Joan; Harold, Justin; Menderes, Gulden Journal: Expert review of anticancer therapy Issue: Volume 22:Issue 6(2022) Page Start: 633 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Uterine Fibroids: Clinical Manifestations and Contemporary Management. (September 2014) Authors: Doherty, Leo; Mutlu, Levent; Sinclair, Donna; Taylor, Hugh Journal: Reproductive sciences Issue: Volume 21:Number 9(2014:Sep.) Page Start: 1067 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗